Related Experiment Video
Updated: Jul 5, 2026
03:07
Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
[Afobazole metabolism in rats].
Eksperimental'Naia I Klinicheskaia Farmakologiia
|May 21, 2008
Summary
Afobazole undergoes extensive metabolism in rats, with 17 biotransformation products identified. Key metabolites include hydroxylated benzimidazole and oxidized morpholine structures, revealing the drug's metabolic fate.
Area of Science:
- Pharmacology
- Drug Metabolism
- Analytical Chemistry
Context:
- Afobazole is an anxiolytic drug.
- Understanding drug metabolism is crucial for pharmacology.
- Mass spectrometry and HPLC are key analytical techniques.
Purpose:
- To investigate the metabolic pathways of afobazole in rats.
- To identify and characterize afobazole metabolites.
- To elucidate the biotransformation products of afobazole.
Summary:
- Afobazole metabolism in rats was studied using mass spectrometry and HPLC.
- Seventeen biotransformation products were identified, including the parent compound.
- Six metabolite structures were confirmed via reference compounds and HPLC/MS; others were characterized by molecular ion masses.
- Significant biotransformation involves hydroxylated benzimidazole and oxidized morpholine moieties.
Impact:
- Provides insights into afobazole's pharmacokinetic profile.
- Contributes to the understanding of drug metabolism and disposition.
- Informs future drug development and safety assessments.
Related Concept Videos
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...